Nectar Lifesciences Ltd. Financials

15:56 May 30

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
27.14
+0.03 (+0.11%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Nectar Lifesciences Ltd. Financials

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
27.14
+0.03 (+0.11%)
15:56 May 30
Quality
image/svg+xml

84/100
High Financial Strength

Valuation
image/svg+xml

76/100
Affordable Valuation

Technical

46/100
Technically Neutral

Strength

11

Weakness

1

Opportunity

1

Threats

0

0.46 %

ROE %

0.22 %

ROA %

0.76

EPS

47.68

BVPS

0.29 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
1543.3 1668.83 1523.67 1684.09 1683.75
Operating Expenses +
1434.25 1510.29 1470.66 1532.53 1507.41
Raw Material
1052.82 1207.32 1200.84 1242.45 1205.34
Increase Decrease in Cost
104.29 15.81 -41.55 -40.21 -31.98
Other Manufacturing Expense
128.62 146.37 172.14 184.64 0
Employee Cost
73.37 74.55 77.78 84.67 96.61
Miscellaneous Expenses
123.99 67.12 61.45 60.98 237.44
Operating Profit
109.05 158.54 53.01 151.56 176.34
Other Income
3.79 11.32 43.18 14.58 3.28
Depreciation
60.25 56.97 59.12 60.72 61.32
Interest
112.04 78.81 79.49 87.14 81.07
Profit before tax and exceptio..
-59.45 34.08 -42.42 18.27 37.23
Exceptional Items
-25.32 0 0 0 0
PBT
-84.77 34.08 -42.42 18.27 37.23
Provision for Taxation
-11.5 9.03 -18.24 13.27 20.25
Net Profit
-73.26 25.05 -24.18 5 17
NET Profit after MI
-73.26 25.05 -24.18 5 17
EPS
-3.27 1.12 -1.08 0.22 0.76
Operating Profit Margin (%)
7.07 9.5 3.48 9 10.47
Net Profit Margin (%)
-4.75 1.5 -1.59 0.3 1.01

Nectar Lifesciences Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 44.50 44.50 55.80 55.80 55.80
FII 1.60 0.70 3.20 16.60 17.00
MF 0.00 0.00 0.00 0.00 0.00
Public 53.60 54.70 40.90 27.60 27.20
Others 0.10 0.00 0.00 0.00 0.00
Others 0.20 0.10 0.10 0.00 0.00
Shareholder Shares Holding %
Download Our App On: